152 related articles for article (PubMed ID: 26971192)
1. Safety of research into severe and treatment-resistant mood disorders: analysis of outcome data from 12 years of clinical trials at the US National Institute of Mental Health.
Nugent AC; Iadarola ND; Miller FG; Luckenbaugh DA; Zarate CA
Lancet Psychiatry; 2016 May; 3(5):436-42. PubMed ID: 26971192
[TBL] [Abstract][Full Text] [Related]
2. The Ethics of Clinical Trials Research in Severe Mood Disorders.
Nugent AC; Miller FG; Henter ID; Zarate CA
Bioethics; 2017 Jul; 31(6):443-453. PubMed ID: 28503892
[TBL] [Abstract][Full Text] [Related]
3. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
[TBL] [Abstract][Full Text] [Related]
4. Development and natural history of mood disorders.
Costello EJ; Pine DS; Hammen C; March JS; Plotsky PM; Weissman MM; Biederman J; Goldsmith HH; Kaufman J; Lewinsohn PM; Hellander M; Hoagwood K; Koretz DS; Nelson CA; Leckman JF
Biol Psychiatry; 2002 Sep; 52(6):529-42. PubMed ID: 12361667
[TBL] [Abstract][Full Text] [Related]
5. Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient care.
Marshall M; Crowther R; Almaraz-Serrano A; Creed F; Sledge W; Kluiter H; Roberts C; Hill E; Wiersma D; Bond GR; Huxley P; Tyrer P
Health Technol Assess; 2001; 5(21):1-75. PubMed ID: 11532238
[TBL] [Abstract][Full Text] [Related]
6. The controversial link between antidepressants and suicidality risks in adults: data from a naturalistic study on a large sample of in-patients with a major depressive episode.
Seemüller F; Riedel M; Obermeier M; Bauer M; Adli M; Mundt C; Holsboer F; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Jäger M; Henkel V; Möller HJ
Int J Neuropsychopharmacol; 2009 Mar; 12(2):181-9. PubMed ID: 18662490
[TBL] [Abstract][Full Text] [Related]
7. Clinical response and risk for reported suicidal ideation and suicide attempts in pediatric antidepressant treatment: a meta-analysis of randomized controlled trials.
Bridge JA; Iyengar S; Salary CB; Barbe RP; Birmaher B; Pincus HA; Ren L; Brent DA
JAMA; 2007 Apr; 297(15):1683-96. PubMed ID: 17440145
[TBL] [Abstract][Full Text] [Related]
8. Lithium for maintenance treatment of mood disorders.
Burgess S; Geddes J; Hawton K; Townsend E; Jamison K; Goodwin G
Cochrane Database Syst Rev; 2001; (3):CD003013. PubMed ID: 11687035
[TBL] [Abstract][Full Text] [Related]
9. Response to letter to the editor from Dr Rahman Shiri: The challenging topic of suicide across occupational groups.
Niedhammer I; Milner A; Witt K; Klingelschmidt J; Khireddine-Medouni I; Alexopoulos EC; Toivanen S; Chastang JF; LaMontagne AD
Scand J Work Environ Health; 2018 Jan; 44(1):108-110. PubMed ID: 29218357
[TBL] [Abstract][Full Text] [Related]
10. NIMH during the tenure of Director Herbert Pardes, M.D. (1978-1984): The President's Commission on Mental Health and the reemergence of NIMH's scientific mission.
Pardes H
Am J Psychiatry; 1998 Sep; 155(9 Suppl):14-9. PubMed ID: 9736859
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of efficacy and treatment-emergent suicidality in adults by psychiatric indication and age subgroup following initiation of paroxetine therapy: a complete set of randomized placebo-controlled trials.
Carpenter DJ; Fong R; Kraus JE; Davies JT; Moore C; Thase ME
J Clin Psychiatry; 2011 Nov; 72(11):1503-14. PubMed ID: 21367354
[TBL] [Abstract][Full Text] [Related]
12. Agitated "unipolar" depression re-conceptualized as a depressive mixed state: implications for the antidepressant-suicide controversy.
Akiskal HS; Benazzi F; Perugi G; Rihmer Z
J Affect Disord; 2005 Apr; 85(3):245-58. PubMed ID: 15780694
[TBL] [Abstract][Full Text] [Related]
13. Does the FDA proposed list of possible correlates of suicidality associated with antidepressants apply to an adult private practice population?
Akiskal HS; Benazzi F
J Affect Disord; 2006 Aug; 94(1-3):105-10. PubMed ID: 16766043
[TBL] [Abstract][Full Text] [Related]
14. Cost and Outcome of Behavioural Activation versus Cognitive Behavioural Therapy for Depression (COBRA): a randomised, controlled, non-inferiority trial.
Richards DA; Ekers D; McMillan D; Taylor RS; Byford S; Warren FC; Barrett B; Farrand PA; Gilbody S; Kuyken W; O'Mahen H; Watkins ER; Wright KA; Hollon SD; Reed N; Rhodes S; Fletcher E; Finning K
Lancet; 2016 Aug; 388(10047):871-80. PubMed ID: 27461440
[TBL] [Abstract][Full Text] [Related]
15. Atypical antipsychotics for disruptive behaviour disorders in children and youths.
Loy JH; Merry SN; Hetrick SE; Stasiak K
Cochrane Database Syst Rev; 2012 Sep; (9):CD008559. PubMed ID: 22972123
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]